Literature DB >> 29141481

Liposome supported peritoneal dialysis in rat amitriptyline exposure with and without intravenous lipid emulsion.

Robin Chapman1, Martyn Harvey2, Paul Davies1, Zimei Wu3, Grant Cave4,5.   

Abstract

Liposome supported peritoneal dialysis is a recently described technique which may eventually be applicable in the clinical scenario of the intoxicated patient. We evaluated the hypothesis that intravenous injection of lipid emulsion (ILE) would augment acidic pH gradient liposome supported peritoneal dialysis (LSPD). Orogastrically amitriptyline dosed rats were treated with either Sodium bicarbonate (NaHCO3) intravenously and standard intraperitoneal dialysate (Group A); NaHCO3 intravenously and LSPD (Group B); or ILE and LSPD (Group C). The primary endpoint was dialysate amitriptyline concentration after a 60 min dwell. Secondary analysis included an estimate of extraction ratio for peritoneal blood flow (ERs). There were significantly higher intraperitoneal concentrations of amitriptyline and ERs in the two groups treated with LSPD (Group B, p = 0.02, Group C, p < 0.01 vs. Group A). There was no observed effect for ILE on intraperitoneal amitriptyline concentration or ERs (p > 0.20). LSPD increased the amitriptyline concentration in peritoneal dialysate. No further increase was demonstrated with ILE. This may be either because such an effect is absent, or type II error. Exploratory analysis suggests LSPD may be driven by total rather than free drug concentrations.

Entities:  

Keywords:  Liposome; amitriptyline; toxicology

Mesh:

Substances:

Year:  2017        PMID: 29141481     DOI: 10.1080/08982104.2017.1403445

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  2 in total

1.  pH Gradient Liposomes Extract Protein Bound Amitriptyline in Peritoneal Dialysis-Exploratory Work.

Authors:  Grant Cave; Rachel Kee; Martyn Harvey; Zimei Wu
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

Review 2.  Liposomes to Augment Dialysis in Preclinical Models: A Structured Review.

Authors:  Kevin Hart; Martyn Harvey; Mingtan Tang; Zimei Wu; Grant Cave
Journal:  Pharmaceutics       Date:  2021-03-16       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.